MARKET

BRCTF

BRCTF

BioArctic AB
OTCPK
38.00
NaN%
Closed 09:30 04/15 EDT
OPEN
--
PREV CLOSE
38.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
40.00
52 WEEK LOW
18.48
MARKET CAP
2.82B
P/E (TTM)
30.43
1D
5D
1M
3M
1Y
5Y
1D
Biogen projects 2026 revenue drop despite Q4 beat
Seeking Alpha · 02/06 12:02
Eisai Announces Filing Of New Drug Application For Leqembi In Japan
NASDAQ · 11/28/2025 06:03
Eisai And Biogen : LEQEMBI IQLIK Injection Now Available In U.S. For Early Alzheimer's Treatment
NASDAQ · 10/07/2025 01:27
Weekly Report: what happened at BRCTF last week (0908-0912)?
Weekly Report · 09/15/2025 10:59
Weekly Report: what happened at BRCTF last week (0901-0905)?
Weekly Report · 09/08/2025 11:01
Weekly Report: what happened at BRCTF last week (0825-0829)?
Weekly Report · 09/01/2025 10:57
BioArctic And Novartis Sign BrainTransporter Option, Collaboration And License Agreement With $30M Upfront Payment Plus Milestones
Benzinga · 08/26/2025 05:39
Weekly Report: what happened at BRCTF last week (0818-0822)?
Weekly Report · 08/25/2025 11:06
More
About BRCTF
BioArctic AB is a Sweden‑based biopharmaceutical company specializing in the discovery and development of disease‑modifying treatments for neurodegenerative disorders. The Company’s primary focus is on conditions that affect the central nervous system (CNS), including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), areas characterized by high unmet medical need and limited effective therapies. BioArctic AB conducts advanced research and development of innovative biological drugs, with a particular emphasis on monoclonal antibodies designed to target the underlying disease mechanisms rather than only alleviating symptoms. The Company combines in‑house scientific expertise with strategic collaborations with global pharmaceutical partners to advance and commercialize its therapeutic candidates worldwide.

Webull offers BioArctic AB stock information, including OTCPK: BRCTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRCTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRCTF stock methods without spending real money on the virtual paper trading platform.